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Monday, March 2, 2009 231aS-transferase-2 is stably associated with them (Clayton et al., 1998). Then an
alternative explanation is that these isoforms also exist in Ctenacroscelis,
and they are alternately arranged and only one of them binds GST-2. The scat-
tering object remains to be identified, but the alternating arrangement of tropo-
myosin isoforms is the most conceivable mechanism to provide the periodicity
needed to create the peculiar meridional reflection.
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Smooth muscle (SM) is unique in its ability to maintain force for long periods
of time at low energy cost. This property is called the latch-state. One of the
assumptions of the latch state model of Hai and Murphy is that myosin must
first be phosphorylated in order to attach to the thin filament. However, we pre-
viously demonstrated that unphosphorylated (unPHOS) myosin can attach to
unregulated actin filaments. The goal of this study was to measure the binding
force of unPHOS SM myosin to tropomyosin-regulated actin filaments. A mi-
crosphere captured in a laser trap was attached to an actin filament decorated
with SM tropomyosin-a and b. The filament was brought in contact with a ped-
estal coated with unPHOS pig antrum myosin. The pedestal was then moved
away from the trap at constant velocity (0.5 mm.s-1). Despite pulling the pedes-
tal away, the microsphere did not move until the force exerted by the trap on the
microsphere was sufficient to overcome the binding force of myosin on the ac-
tin/tropomyosin filament. At this point, the microsphere sprang back to its un-
loaded position. The force of unbinding was calculated as the product of the
trap stiffness and the maximal displacement of the trapped microsphere, as as-
sessed by displacement of its center of mass. The average force of unbinding
per myosin molecule (Funb) was obtained by dividing the measured force of un-
binding by the number of myosin molecules estimated per actin filament length.
We found that Funb was greater in presence (0.222 pN 5 0.018; mean5SE)
than in absence (0.142 pN 5 0.019; p<0.001) of tropomyosin. These results
demonstrate that tropomyosin strengthens the bond between unPHOS myosin
and actin. Future studies will investigate the role of other regulatory proteins
of the thin filament.
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Movement of tropomyosin (Tm) on thin filaments in response to Ca2þ-binding
to troponin and myosin binding to actin is an inherent feature of muscle reg-
ulation. As part of this process, the cable-like mechanical properties of the Tm
coiled-coil are thought to underlie cooperative on and off switching of con-
traction. In principle, movement of Tm over the flat surface of actin may
not require significant molecular flexibility. However, local perturbations
caused, for example, by myosin binding on actin may necessitate some plas-
ticity of the Tm molecule. In contrast, any large-scale Tm flexibility might
dampen its cooperative movement. In the current study, we directly assessed
the flexibility of Tm by examining EM images of both rotary shadowed and
negatively stained molecules. Single Tm molecules in both image sets showed
no obvious signs of sharp bending or kinks, and displayed contours close to
those predicted from a high-resolution 3D model of Tm (Lorenz et al.,
1995). Short multimeric strings of end-to-end bonded Tm were commonly ob-
served in the rotary shadowed images. These showed no pronounced bending
or joints at the intermolecular junctions. The persistence length of Tm was cal-
culated to be over twice the length of the molecule based on these EM images.
The data as a whole imply that Tm molecules exhibit an intrinsic stiffness suf-
ficient to contribute to cooperativity on thin filaments and thus are consistent
with models of muscle regulation (e.g. Lehrer & Geeves, 1998; Lehman et al.,
2000). A tropomyosin mutant in which the coiled-coil interface was destabi-
lized by introduction of Ala clusters in the 2nd and 3rd periodic repeats
(Y60A-L64A-L106A; Singh & Hitchcock-DeGregori, unpublished) was also
examined by EM. No obvious extra bending was observed, although the cal-
culated persistence length was significantly shortened, showing the sensitivity
of the technique.1189-Pos Board B33
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Previously, we have discovered small molecules that increase cardiac contrac-
tility by directly activating the cardiac sarcomere; this mechanism is now being
investigated as a therapy for treating systolic heart failure. Using this precedent,
we have focused on the identification of compounds that directly increase
skeletal muscle contractility for the potential therapy of diseases that result
in muscle weakness and fatigue.
CK-1909178 is a member of a class of fast skeletal troponin activators that were
identified by high throughput screening of skeletal sarcomere preparations. We
sought to understand how this compound altered force development in isomet-
ric skinned and live muscle fibers. Treatment of skinned rabbit psoas fibers with
0.1 mM CK-1909178 caused a dose-dependent left-shift of the force-pCa rela-
tionship without altering the Hill slope or maximum force, consistent with a cal-
cium sensitizing effect on force production. In living rat flexor digitorum brevis
(FDB) preparations, CK-1909178 (10 mM) caused significant increases in sub-
tetanic force (150% of control at 10 Hz) without altering maximum force. Sim-
ilar experiments were then performed using a rat extensor digitorum longus
(EDL) preparation in-situ, where nervous and vascular connections were left
intact and the muscle was stimulated via the peroneal nerve. Infusions of
CK-1909178 up to 10 mg/kg rapidly increased sub-tetanic isometric force
(190% of control at 30 Hz). In summary, we have identified a skeletal troponin
activator that sensitizes the sarcomere to calcium and results in increased sub-
maximal muscle force development in-vitro and in-situ. We believe that this
mechanism may translate to improved physical power and strength in diseases
where muscle function is compromised due to injury, disease or age.
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Striated muscle contraction is tightly coupled to the release of Ca2þ from the
sarcoplasmic reticulum by the sarcomeric calcium sensor, troponin. This com-
plex of three proteins (troponins T, I, and C) undergoes calcium-sensitive con-
formational changes that regulate the accessibility of myosin binding sites
along the actin filament. We used a high throughput screen to identify com-
pounds that activate the ATPase activity of skinned fast skeletal myofibrils;
optimization of the initial hit compounds has resulted in compounds with
sub-micromolar affinity. A potent representative of this chemical series, CK-
1909178, shifts the calcium sensitivity of detergent skinned skeletal myofibrils
by >10-fold in a concentration dependent manner. This compound specifically
activates fast skeletal myofibrils, with no effect on either slow skeletal or car-
diac myofibrils. A reconstituted sarcomere assay using combinations of fast
skeletal, slow skeletal, and cardiac components demonstrates that the activity
of CK-1909178 requires the presence of fast skeletal troponin. Isothermal titra-
tion calorimetry indicates the compound binds directly to fast skeletal troponin
with a sub-micromolar dissociation constant. Consistent with its calcium sen-
sitization effects, CK-1909178 slows the dissociation of calcium from troponin
as measured by Quin-2 fluorescence. Consistent with its mechanism of action,
CK-1909178 sensitizes muscle in vitro and in vivo, suggesting this mechanism
may increase power or strength in diseases where muscle function is compro-
mised due to injury, disease or age.
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The binding of Ca2þ to cardiac troponin C (cTnC) triggers contraction in heart
muscle. In diseased heart, the myocardium is often desensitized to Ca2þ, lead-
ing to weak cardiac contractility. Compounds that can sensitize cardiac muscle
to Ca2þ have therapeutic value in treating heart failure. Of the known drugs
that are proposed to accomplish this, levosimendan is the best characterized
and currently in clinical use. Levosimendan interacts with the regulatory do-
main of cTnC and promotes association of cTnC with troponin I (cTnI). De-
tailed understanding of the mechanism of levosimendan has been concealed
by its unstable nature; however, the use of analogues that are more stable would
232a Monday, March 2, 2009provide valuable insights into its mode of action. The molecular framework of
DFBP resembles that of levosimendan, thus it was chosen to mimic levosimen-
dan to establish how the cTnC-cTnI binding equilibrium is modulated. We have
utilized 2D {1H, 15N} HSQC and 2D {1H, 13C} HSQC NMR spectroscopy to
examine the binding of DFBP to cNTnCCa2þ in the absence and presence of
cTnI144-163 and of cTnI144-163 to cNTnCCa2þ in the absence and presence
of DFBP. The results show that DFBP and cTnI144-163 bind cNTnCCa2þ
concurrently and the affinity of DFBP for cNTnCCa2þ is increased ~5-10-
fold by cTnI144-163. We are in the process of determining the NMR solution
structure of cNTnCCa2þcTnI144-163DFBP. This structure will contribute
to the understanding of the mechanism of action of levosimendan in the therapy
of heart disease. It will also provide a structural basis for the design of Ca2þ-
sensitizing drugs in general.
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The loss of slow skeletal muscle troponin T (TnT) results in a severe type of
nemaline myopathy in the Amish (ANM). The genes encoding TnT and tropo-
nin I (TnI) are closely linked in pairs in which the 50-enhancer region of the
slow TnT gene overlaps with the cardiac TnI gene. In a mouse line with the en-
tire cardiac TnI gene deleted, a partial destruction of the slow TnT gene pro-
moter produces a knockdown effect. By crossing with transgenic mouse lines
that over-express a core structure of cardiac TnI (cTnI-ND) under the control
of cloned alpha-MHC promoter, we rescued the postnatal lethality of the car-
diac TnI gene-deleted mice with no detrimental cardiac phenotypes or leaking
expression in non-cardiac tissues. The double transgenic mice exhibited de-
creased expression of slow TnT mRNA and protein in adult diaphragm muscle.
Functional analysis of isolated muscle strips showed that the slow TnT deficient
(sTnT-KD) diaphragm had significantly decreased fatigue tolerance evident by
the faster decrease in force and slower rate of recovery as compared with that in
wild type controls. As a consequence of slow TnT deficiency, the sTnT-KD di-
aphragm muscle contained a higher proportion of fast TnT, decreased slow TnI
with increased fast TnI, and decreased type I myosin with increased type II my-
osin. Consistent with the switch toward fast myofilament contents, the sTnT-
KD diaphragm muscle produced higher specific tension in twitch and tetanic
contractions as well as shorter time to develop peak tension in twitch contrac-
tions. The decreased fatigue tolerance of sTnT-KD diaphragm muscle explains
the terminal respiratory failure seen in virtually all ANM patients and this dou-
ble transgenic mouse model provides a useful experimental system to study the
pathogenesis and treatment of ANM.
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Oscillatory contraction of insect indirect flight muscle (IFM) is activated by si-
nusoidal length changes. Work done by oscillating fibres is measured from the
area of loops on a length-tension plot. At [Ca2þ] above 10 mM, progressively
less oscillatory work is produced because fibres contract isometrically and are
unable to relax fully after each cycle of oscillation. Periodic stretches during
oscillations activate fibres through the action of TnC F1, which binds one
Ca2þ in the C-lobe. Activation of isometric contraction by Ca2þ acts through
F2, which binds Ca2þ in both N- and C-lobes. Lethocerus IFM fibres
substituted with F1gave oscillatory work, which did not decline at high
[Ca2þ], while fibres substituted with F2 produced more isometric tension as
[Ca2þ] was increased. Varying proportions of F1 and F2 gave maximal
work with an F1:F2 ratio of 100:1, which is higher than the in vivo ratio of
7:1. The structure of F1, and the interaction with TnI, were determined by
NMR. The N-lobe of F1 is in the closed conformation in apo and Ca2þ- bound
forms and does not bind TnI. Unexpectedly, the C-lobe is open in both states,
and binds the N-terminal domain of TnI independently of Ca2þ. The affinity of
F1and F2 for a complex containing tropomyosin, TnT and TnH (Lethocerus
TnI) were measured by isothermal calorimetry in the presence of Ca2þ. The
affinities of F1 and F2 for the complex were 5.4 mm and 65 nM respectively.
This difference is likely to be due to a single TnI binding site on F1 and two
sites on F2. Stretch may be sensed by an extended C-terminal domain of
TnH, and transmitted to the C-lobe of F1, resulting in a change in the interac-
tion of the TnI inhibitory domain and actin.1194-Pos Board B38
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The mechanical characteristics of titin in muscle sarcomeres were previously
studied by us in single myofibril stretch experiments, where the extensibility
of I-band titin segments was usually measured under static conditions. Here
we investigated the behavior of I-band titin during and after stretch of single
rabbit psoas myofibrils in real-time. The focus was on titin’s proximal Ig-do-
main region, whose stretch dynamics were analyzed by labeling the myofibrils
specifically in the N2A-titin domain using antibody-conjugated quantum dots,
which stained the periphery of the myofibril but did not enter the myofilament
lattice. Qdot labels were tracked to obtain the stretch-dependent change in epi-
tope distance (across Z-disc) and sarcomere length (SL) over time. In contrast
to what was expected from the current titin extensibility model, at sarcomere
lengths of 2.5 and 3.8 mm, titin’s proximal Ig-domain region elongated contin-
uously, in proportion to the half I-band length. Already at ~2.6 mm SL the prox-
imal Ig-segment length exceeded the value expected if all Ig-domains remain
folded. Our results suggest that Ig-domains unfold in parallel with PEVK-titin
extension at physiological sarcomere lengths and under relatively low forces.
By reducing the antibody-Qdot concentration, we succeeded in observing titin
Ig-domain dynamics in myofibrils at the single-molecule level.
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Protein kinase A-mediated (PKA) phosphorylation of cardiac myosin binding
protein-C (cMyBP-C) accelerates the kinetics of cross-bridge cycling and ap-
pears to relieve the tether-like constraint of myosin heads imposed by
cMyBP-C (Colson et al., 2008,Circ Res., 103:244-251). We favor a mechanism
in which phosphorylation of the 3 PKA sites in cMyBP-C modulates cross-
bridge kinetics by regulating the proximity and interaction of myosin with
actin. To test this idea, we used synchrotron low-angle x-ray diffraction and
mechanical measurements in skinned myocardium isolated from a mouse
model with phosphomimetic substitutions in cMyBP-C, i.e., the CTSD mouse.
The substitutions were introduced by transgenic expression of cMyBP-C with
Ser-to-Asp mutations on a cMyBP-C null background. Western blots showed
that expression of CTSD cMyBP-C was 85% of wild-type (WT), and the heart
weight to body weight ratio was similar (5.2 5 0.2 mg/g) in CTSD and WT
mice. Expression of WT cMyBP-C on the knockout background served as con-
trol (i.e., the CTWT mouse). Skinned myocardium from CTSD and CTWT
mice exhibited similar maximum active forces (mN/mm2: 17.7 5 3.7 vs
13.2 5 2.9), Ca2þ-sensitivities of force (pCa50: 5.55 5 0.03 vs 5.58 5
0.04), and maximum rates of force development (ktr, sec
-1: 20.2 5 1.7 vs
22.5 5 1.9; kdf, sec
-1: 37.6 5 3.7 vs 43.2 5 2.3). I11/I10 intensity ratios and
d10 lattice spacings determined from equatorial reflections from CTSD and
CTWT myocardium were used to determine the effect of constitutive
cMyBP-C phosphorylation on the distribution of cross-bridge mass between
the thick and thin filaments and on interfilament lattice spacing. The results
suggest that interactions between cMyBP-C and the S2 domain of myosin
heavy chain are dynamically regulated by phosphorylations in the cMyBP-C
motif. (AHA-predoctoral fellowship (BAC); NIH-HL-R01-82900)
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Obscurin is a multidomain protein composed of adhesion and signaling do-
mains that plays key roles in the organization of contractile and membrane
structures in striated muscles. We used adenoviral-mediated gene transfer to
overexpress its extreme NH2-terminus in developing myofibers, followed by
immunofluorescence and ultrastructural methods to study its effects in sarco-
merogenesis. We found that overexpression of obscurin’s second immunoglob-
ulin domain (Ig2) inhibits the assembly of A- and M-bands, but not Z-disks and
